Suppr超能文献

脓毒性休克患者持续肾脏替代治疗(CRRT)的影响因素:一项全国住院患者样本数据库分析

Factors Affecting Continuous Renal Replacement Therapy (CRRT) in Patients With Septic Shock: An Analysis of a National Inpatient Sample Database.

作者信息

Yagnik Karan, Mohan Gaurav, Ketkar Apurva, Nivera Noel, Weiner Sharon, Patton Chandler, Du Doantrang

机构信息

Internal Medicine, Monmouth Medical Center, Long Branch, USA.

Nephrology, Monmouth Medical Center, Long Branch, USA.

出版信息

Cureus. 2024 Nov 24;16(11):e74356. doi: 10.7759/cureus.74356. eCollection 2024 Nov.

Abstract

BACKGROUND

Septic shock is defined as sepsis with hypotension requiring vasopressors to maintain a mean arterial pressure above 65 mmHg and having a serum lactate level of more than 2 mmol/L despite adequate volume resuscitation as per the Sepsis-3 criteria. Continuous renal replacement therapy (CRRT) is commonly utilized in septic shock patients for the treatment of acute kidney injury as well as for modulating immune response and maintaining hemodynamic stability.

METHODS

We looked at the National Inpatient Sample database in 2019. We identified adult patients with septic shock as the primary diagnosis using the International Classification of Diseases, 10th revision, clinical modification codes R65.21 and R78.81, and subbranches of Aa41, A40, and R60. STATA 18 (StataCorp, College Station, TX) was used to perform logistic multivariate regression analyses.

RESULTS

A total of 15,794 adults who were admitted for septic shock as the primary diagnosis underwent CRRT. The mean age of the patients was 61.7 years. The overall mortality rate was 57% (N = 9,002). An increase in age by one year was associated with a 1% increase in mortality (p = 0.001). The presence of hypertension increased mortality by 29% (N = 6,391) (p = 0.028). Interestingly, preexisting diabetes mellitus improved mortality by 37% (N = 3331) (p = 0.001).The outcome of CRRT was better in patients with chronic kidney disease, with a 26% improvement in mortality (N = 2341) (p = 0.001). A significant improvement in outcome (29% decrease in mortality, p=0.013) and 31% reduction in hospital length of stay (p = 0.008) was noted with CRRT initiated on day 2 of hospitalization.

CONCLUSION

This study highlights that the approximate time of initiation of CRRT for optimal benefit of the treatment is between 24 and 48 hours of hospitalization. This study emphasizes the prognostic factors of a standard therapy, which can serve as a basis for clinical decision-making.

摘要

背景

脓毒性休克的定义为符合脓毒症-3标准的脓毒症,伴有低血压,需要使用血管升压药维持平均动脉压高于65 mmHg,且在充分液体复苏后血清乳酸水平仍超过2 mmol/L。连续性肾脏替代治疗(CRRT)常用于脓毒性休克患者,以治疗急性肾损伤以及调节免疫反应和维持血流动力学稳定。

方法

我们查阅了2019年的全国住院患者样本数据库。我们使用国际疾病分类第10版临床修订版代码R65.21和R78.81以及Aa41、A40和R60的子分支,将以脓毒性休克为主要诊断的成年患者识别出来。使用STATA 18(StataCorp,德克萨斯州大学站)进行逻辑多元回归分析。

结果

共有15794名以脓毒性休克为主要诊断入院的成年人接受了CRRT治疗。患者的平均年龄为61.7岁。总体死亡率为57%(n = 9002)。年龄每增加一岁,死亡率增加1%(p = 0.001)。高血压的存在使死亡率增加29%(n = 6391)(p = 0.028)。有趣的是,既往糖尿病使死亡率降低了37%(n = 3331)(p = 0.001)。慢性肾病患者接受CRRT的治疗效果更好,死亡率降低了26%(n = 2341)(p = 0.001)。在住院第2天开始进行CRRT时,观察到治疗效果有显著改善(死亡率降低29%,p = 0.013),住院时间缩短31%(p = 0.008)。

结论

本研究强调,为使治疗获得最佳效益,CRRT的起始时间约在住院24至48小时之间。本研究强调了标准治疗的预后因素,可为临床决策提供依据。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验